Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Covington
Federal Trade Commission
Healthtrust
Citi
UBS
Cipla
Chubb
Fish and Richardson

Generated: April 21, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 008816

« Back to Dashboard

NDA 008816 describes XYLOCAINE, which is a drug marketed by Astrazeneca, Fresenius Kabi Usa, Oak Pharms, and Dentsply Pharm, and is included in fourteen NDAs. It is available from six suppliers. Additional details are available on the XYLOCAINE profile page.

The generic ingredient in XYLOCAINE is epinephrine; lidocaine hydrochloride. There are nineteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the epinephrine; lidocaine hydrochloride profile page.
Summary for 008816
Tradename:XYLOCAINE
Applicant:Oak Pharms
Ingredient:lidocaine hydrochloride
Patents:0
Therapeutic Class:Anesthetics
Formulation / Manufacturing:see details
Pharmacology for NDA: 008816
Ingredient-typeAmides
Physiological EffectLocal Anesthesia
Suppliers and Packaging for NDA: 008816
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XYLOCAINE lidocaine hydrochloride JELLY;TOPICAL 008816 NDA Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) 76478-479 N 76478-479-30
XYLOCAINE lidocaine hydrochloride JELLY;TOPICAL 008816 NDA Oak Pharmaceuticals, Inc. (Subsidiary of Akorn, Inc.) 76478-479 N 76478-479-05

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:JELLY;TOPICALStrength2%
Approval Date:Approved Prior to Jan 1, 1982TE:ATRLD:Yes

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Chubb
Harvard Business School
Boehringer Ingelheim
QuintilesIMS
Dow
McKinsey
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.